S100鈣結合蛋白A6(S100A6)重組蛋白
Recombinant S100 Calcium Binding Protein A6 (S100A6)
S100-A6; 2A9; 5B10; CABP; CACY; PRA; MLN 4; Calcyclin; Growth factor-inducible protein 2A9; Prolactin receptor-associated protein
- 編號RPB769Ra01
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量11.3kDa
- 實際分子量11kDa(差異分析請參閱說明書)
- 片段與標簽Met1~Lys89 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點6.2
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 912 ¥ 2280 ¥ 4560 ¥ 13680 ¥ 34200
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure. Gene Sequencing (Extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB769Ra01 | S100鈣結合蛋白A6(S100A6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB769Ra01 | S100鈣結合蛋白A6(S100A6)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB769Ra71 | S100鈣結合蛋白A6(S100A6)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAB769Ra21 | S100鈣結合蛋白A6(S100A6)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB769Ra | S100鈣結合蛋白A6(S100A6)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB769Ra | S100鈣結合蛋白A6(S100A6)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| KSB769Ra01 | S100鈣結合蛋白A6(S100A6)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Proteomics | Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction [PubMed: 23201116] |
| Tumour Biol | Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer [PubMed: 26361956] |
| Clinical and Translational Medicine | Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma [pubmed:27709523] |
| Gastroenterology | Tu1938-Micronutrients Assessment in Patients with Cirrhosis [10.1016:S0016-5085(18)33544-3] |
| Gastroenterology | Tu1942-PI3K/AKT-Mediated Upregulation of C7 Inhibits Colorectal Cancer Proliferation and Metastasis [10.1016:S0016-5085(18)33544-5] |
| Tumor?Biology | Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma [Pubmed:29629840] |
| scandinavian journal of clinical & laboratory investigation | Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study [Pubmed: 31856598] |
| CELL BIOCHEMISTRY AND FUNCTION | S100A6 represses Calu?\6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis [34008212] |
| MOLECULAR VISION | Quantification of a panel for dry-eye protein biomarkers in tears: A comparative pilot study using standard ELISA and customized microarrays [34012227] |
留言咨詢
